AU2001272238A1 - CLK-2, CEX-7 and COQ-4 genes, and uses thereof - Google Patents
CLK-2, CEX-7 and COQ-4 genes, and uses thereofInfo
- Publication number
- AU2001272238A1 AU2001272238A1 AU2001272238A AU7223801A AU2001272238A1 AU 2001272238 A1 AU2001272238 A1 AU 2001272238A1 AU 2001272238 A AU2001272238 A AU 2001272238A AU 7223801 A AU7223801 A AU 7223801A AU 2001272238 A1 AU2001272238 A1 AU 2001272238A1
- Authority
- AU
- Australia
- Prior art keywords
- seq
- clk
- gene
- protein
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101100113692 Caenorhabditis elegans clk-2 gene Proteins 0.000 title claims description 273
- 101150002460 COQ4 gene Proteins 0.000 title claims description 35
- 108090000623 proteins and genes Proteins 0.000 claims description 111
- 108091035539 telomere Proteins 0.000 claims description 71
- 102000055501 telomere Human genes 0.000 claims description 71
- 210000003411 telomere Anatomy 0.000 claims description 71
- 101100011369 Caenorhabditis elegans egl-26 gene Proteins 0.000 claims description 44
- 230000035772 mutation Effects 0.000 claims description 42
- 230000000694 effects Effects 0.000 claims description 41
- 102000004169 proteins and genes Human genes 0.000 claims description 40
- 150000001875 compounds Chemical class 0.000 claims description 32
- 101150026243 clk-2 gene Proteins 0.000 claims description 31
- 210000001519 tissue Anatomy 0.000 claims description 29
- 210000000056 organ Anatomy 0.000 claims description 27
- 230000001413 cellular effect Effects 0.000 claims description 26
- 241001465754 Metazoa Species 0.000 claims description 25
- 230000033228 biological regulation Effects 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 20
- 230000035479 physiological effects, processes and functions Effects 0.000 claims description 20
- 230000014509 gene expression Effects 0.000 claims description 16
- 230000002452 interceptive effect Effects 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 241000282414 Homo sapiens Species 0.000 claims description 12
- 230000019522 cellular metabolic process Effects 0.000 claims description 12
- 230000030279 gene silencing Effects 0.000 claims description 10
- 230000001575 pathological effect Effects 0.000 claims description 10
- 230000009467 reduction Effects 0.000 claims description 10
- 101150101112 7 gene Proteins 0.000 claims description 8
- 230000007246 mechanism Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 230000002018 overexpression Effects 0.000 claims description 7
- 241001529936 Murinae Species 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 6
- 238000003209 gene knockout Methods 0.000 claims description 6
- 108091081400 Subtelomere Proteins 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 238000004904 shortening Methods 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 32
- 235000013601 eggs Nutrition 0.000 description 28
- 101100328957 Caenorhabditis elegans clk-1 gene Proteins 0.000 description 26
- 238000011161 development Methods 0.000 description 23
- 230000018109 developmental process Effects 0.000 description 23
- 230000006870 function Effects 0.000 description 21
- 239000002299 complementary DNA Substances 0.000 description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 17
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 17
- 239000012634 fragment Substances 0.000 description 15
- 230000008774 maternal effect Effects 0.000 description 15
- 244000068988 Glycine max Species 0.000 description 14
- 235000010469 Glycine max Nutrition 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 13
- 210000000349 chromosome Anatomy 0.000 description 12
- 210000002257 embryonic structure Anatomy 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 210000004602 germ cell Anatomy 0.000 description 10
- 230000013020 embryo development Effects 0.000 description 9
- 230000010196 hermaphroditism Effects 0.000 description 9
- 101150039113 unc-36 gene Proteins 0.000 description 9
- 241000244203 Caenorhabditis elegans Species 0.000 description 8
- 230000001665 lethal effect Effects 0.000 description 8
- 210000000287 oocyte Anatomy 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 101100098479 Caenorhabditis elegans glp-4 gene Proteins 0.000 description 7
- 101150076104 EAT2 gene Proteins 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- 230000013933 post-embryonic development Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 101100447050 Caenorhabditis elegans daf-16 gene Proteins 0.000 description 6
- 101100074829 Caenorhabditis elegans lin-13 gene Proteins 0.000 description 6
- 101100257133 Caenorhabditis elegans sma-3 gene Proteins 0.000 description 6
- 101000770593 Homo sapiens 5-demethoxyubiquinone hydroxylase, mitochondrial Proteins 0.000 description 6
- 101100113694 Mus musculus Clk2 gene Proteins 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 230000006399 behavior Effects 0.000 description 6
- 238000012217 deletion Methods 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 231100000518 lethal Toxicity 0.000 description 6
- 102100029272 5-demethoxyubiquinone hydroxylase, mitochondrial Human genes 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 5
- 108700019146 Transgenes Proteins 0.000 description 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000003542 behavioural effect Effects 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 241000219195 Arabidopsis thaliana Species 0.000 description 4
- 101100181928 Caenorhabditis elegans lin-39 gene Proteins 0.000 description 4
- 101100428693 Caenorhabditis elegans unc-32 gene Proteins 0.000 description 4
- 101100168147 Mus musculus Coq4 gene Proteins 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000021121 meiosis Effects 0.000 description 4
- 230000017448 oviposition Effects 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 108700023601 C elegans clk-2 Proteins 0.000 description 3
- 101100502610 Caenorhabditis elegans fem-2 gene Proteins 0.000 description 3
- 101100075830 Caenorhabditis elegans mab-5 gene Proteins 0.000 description 3
- 101100257134 Caenorhabditis elegans sma-4 gene Proteins 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101000738400 Homo sapiens Cyclin-dependent kinase 11B Proteins 0.000 description 3
- 101000875780 Homo sapiens Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000020934 caloric restriction Nutrition 0.000 description 3
- 230000010094 cellular senescence Effects 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000001973 epigenetic effect Effects 0.000 description 3
- 101150014310 fem-3 gene Proteins 0.000 description 3
- 230000004720 fertilization Effects 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 3
- 230000003362 replicative effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 229940035936 ubiquinone Drugs 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- 101100221565 Caenorhabditis elegans coq-4 gene Proteins 0.000 description 2
- 101100511466 Caenorhabditis elegans lon-1 gene Proteins 0.000 description 2
- 101100083339 Caenorhabditis elegans unc-11 gene Proteins 0.000 description 2
- 208000037051 Chromosomal Instability Diseases 0.000 description 2
- 241000255601 Drosophila melanogaster Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 101000749291 Homo sapiens Dual specificity protein kinase CLK2 Proteins 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 2
- 102100035953 Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial Human genes 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000020973 chromatin silencing at telomere Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 231100001129 embryonic lethality Toxicity 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000004777 loss-of-function mutation Effects 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000000392 somatic effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 241001147672 Ancylostoma caninum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100328955 Bos taurus COQ4 gene Proteins 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000019330 Dimethylallyltransferases Human genes 0.000 description 1
- 108010006731 Dimethylallyltranstransferase Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 101100060954 Drosophila melanogaster Coq4 gene Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 101000597183 Homo sapiens Telomere length regulation protein TEL2 homolog Proteins 0.000 description 1
- 241000219828 Medicago truncatula Species 0.000 description 1
- 108010058682 Mitochondrial Proteins Proteins 0.000 description 1
- 102000006404 Mitochondrial Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000209094 Oryza Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000012425 Polycomb-Group Proteins Human genes 0.000 description 1
- 108010022429 Polycomb-Group Proteins Proteins 0.000 description 1
- 241000192142 Proteobacteria Species 0.000 description 1
- 241000700161 Rattus rattus Species 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 102000004535 Tankyrases Human genes 0.000 description 1
- 108010017601 Tankyrases Proteins 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 102100035154 Telomere length regulation protein TEL2 homolog Human genes 0.000 description 1
- 102000010823 Telomere-Binding Proteins Human genes 0.000 description 1
- 108010038599 Telomere-Binding Proteins Proteins 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 230000007488 abnormal function Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 230000024321 chromosome segregation Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000034002 defecation rhythm Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000002074 deregulated effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001152 differential interference contrast microscopy Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000012361 double-strand break repair Effects 0.000 description 1
- 230000008143 early embryonic development Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 230000027632 eggshell formation Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000034004 oogenesis Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000034408 response to ionizing radiation Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000027387 rhythmic behavior Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 102100023397 tRNA dimethylallyltransferase Human genes 0.000 description 1
- 108030001808 tRNA dimethylallyltransferases Proteins 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- DBESHHFMIFSNRV-RJYQSXAYSA-N ubiquinone-7 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O DBESHHFMIFSNRV-RJYQSXAYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
- C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21317400P | 2000-06-22 | 2000-06-22 | |
| US60/213,174 | 2000-06-22 | ||
| US25493200P | 2000-12-13 | 2000-12-13 | |
| US60/254,932 | 2000-12-13 | ||
| PCT/CA2001/000913 WO2001098478A2 (en) | 2000-06-22 | 2001-06-20 | Clk-2, cex-7 and coq-4 genes, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001272238A1 true AU2001272238A1 (en) | 2002-01-02 |
Family
ID=26907831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001272238A Abandoned AU2001272238A1 (en) | 2000-06-22 | 2001-06-20 | CLK-2, CEX-7 and COQ-4 genes, and uses thereof |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20030162291A1 (https=) |
| EP (1) | EP1325124A2 (https=) |
| JP (1) | JP2004500878A (https=) |
| AU (1) | AU2001272238A1 (https=) |
| CA (1) | CA2413452A1 (https=) |
| IL (1) | IL153573A0 (https=) |
| WO (1) | WO2001098478A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1325124A2 (en) * | 2000-06-22 | 2003-07-09 | McGILL UNIVERSITY | Clk-2, cex-7 and coq-4 genes, and uses thereof |
| US8450302B2 (en) * | 2002-08-02 | 2013-05-28 | Ab Science | 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| US7329495B2 (en) | 2004-06-09 | 2008-02-12 | Board Of Regents, The University Of Texas System | Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors |
| US8361976B2 (en) | 2004-07-09 | 2013-01-29 | University Of Massachusetts | Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules |
| WO2006037224A1 (en) * | 2004-10-06 | 2006-04-13 | Mcgill University | Isolated clk-1 -i- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders |
| ATE544071T1 (de) * | 2005-03-03 | 2012-02-15 | Sirtris Pharmaceuticals Inc | Fluoreszenzpolarisationstests für die acetyltransferase-deacetylase-aktivität |
| JP5514401B2 (ja) | 2005-09-21 | 2014-06-04 | 国立大学法人広島大学 | Ｇテイル配列の長さ測定方法及びそれに用いるキット |
| AU2006339607A1 (en) * | 2005-12-02 | 2007-09-13 | Sirtris Pharmaceuticals, Inc. | Modulators of Cdc2-like kinases (Clks) and methods of use thereof |
| EP1955077B1 (en) * | 2005-12-02 | 2012-06-13 | Sirtris Pharmaceuticals, Inc. | Mass spectrometry assays for acetyltransferase/deacetylase activity |
| TW201803890A (zh) | 2007-02-02 | 2018-02-01 | 艾瑟勒朗法瑪公司 | 衍生自ＡｃｔＲＩＩＢ的變體與其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0932701A1 (en) * | 1996-10-21 | 1999-08-04 | McGILL UNIVERSITY | STRUCTURAL AND FUNCTIONAL CONSERVATION OF THE C. ELEGANS CLOCK GENE clk-1 |
| EP1325124A2 (en) * | 2000-06-22 | 2003-07-09 | McGILL UNIVERSITY | Clk-2, cex-7 and coq-4 genes, and uses thereof |
-
2001
- 2001-06-20 EP EP01951254A patent/EP1325124A2/en not_active Withdrawn
- 2001-06-20 JP JP2002504626A patent/JP2004500878A/ja active Pending
- 2001-06-20 AU AU2001272238A patent/AU2001272238A1/en not_active Abandoned
- 2001-06-20 CA CA002413452A patent/CA2413452A1/en not_active Abandoned
- 2001-06-20 WO PCT/CA2001/000913 patent/WO2001098478A2/en not_active Ceased
- 2001-06-20 IL IL15357301A patent/IL153573A0/xx unknown
- 2001-06-20 US US10/312,187 patent/US20030162291A1/en not_active Abandoned
-
2003
- 2003-01-22 US US10/349,507 patent/US20030199002A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1325124A2 (en) | 2003-07-09 |
| US20030199002A1 (en) | 2003-10-23 |
| US20030162291A1 (en) | 2003-08-28 |
| IL153573A0 (en) | 2003-07-06 |
| WO2001098478A3 (en) | 2003-05-01 |
| CA2413452A1 (en) | 2001-12-27 |
| JP2004500878A (ja) | 2004-01-15 |
| WO2001098478A2 (en) | 2001-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bénard et al. | The C. elegans maternal-effect gene clk-2 is essential for embryonic development, encodes a protein homologous to yeast Tel2p and affects telomere length | |
| Sieburth et al. | SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans | |
| Miller et al. | lin-31, a Caenorhabditis elegans HNF-3/fork head transcription factor homolog, specifies three alternative cell fates in vulval development. | |
| Inoue et al. | Targets of TGF-β signaling in Caenorhabditis elegans dauer formation | |
| Schmidt et al. | Genetic and molecular characterization of sting, a gene involved in crystal formation and meiotic drive in the male germ line of Drosophila melanogaster | |
| Kreutzer et al. | Caenorhabditis elegans cyclin A-and B-type genes: a cyclin A multigene family, an ancestral cyclin B3 and differential germline expression | |
| Yochem et al. | C. elegans NIMA-related kinases NEKL-2 and NEKL-3 are required for the completion of molting | |
| Calgaro et al. | The Drosophila gene taranis encodes a novel trithorax group member potentially linked to the cell cycle regulatory apparatus | |
| AU2001272238A1 (en) | CLK-2, CEX-7 and COQ-4 genes, and uses thereof | |
| Willis et al. | Conditional dominant mutations in the Caenorhabditis elegans gene act-2 identify cytoplasmic and muscle roles for a redundant actin isoform | |
| WO2000076308A1 (en) | Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism | |
| EP1374672B1 (en) | Drosophila strain carrying bradeion gene(s) transferred thereinto | |
| Hayashizaki et al. | Characterization of the C. elegans gap‐2 gene encoding a novel Ras‐GTPase activating protein and its possible role in larval development | |
| AU743527B2 (en) | Structural and functional conservation of the C. elegans clock gene clk-1 | |
| Rushforth et al. | Functions of the Caenorhabditis elegans regulatory myosin light chain genes mlc-1 and mlc-2 | |
| WO2001018549A1 (en) | Method for identifying modulators of daf-16 | |
| US20030187246A1 (en) | Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof | |
| Kasravi et al. | Molecular cloning and tissue-specific expression of the mutator2 gene (mu2) in Drosophila melanogaster | |
| Ronsseray et al. | P element regulation and X-chromosome subtelomeric heterochromatin in Drosophila melanogaster | |
| Ji et al. | Characterization of STIP, a multi-domain nuclear protein, highly conserved in metazoans, and essential for embryogenesis in Caenorhabditis elegans | |
| US20050054592A1 (en) | Identification of ses-1 and the uses of the same | |
| WO2004024084A2 (en) | Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling | |
| Horowitz et al. | C. elegans E3 ubiquitin ligase EBAX-1 promotes non-apoptotic linker cell-type death through target-directed miRNA degradation | |
| Jia et al. | embryogenesis in Caenorhabditis elegans | |
| Mantina | TEG-4 is a splicing factor involved in regulating the balance between proliferation and differentiation in the c. elegans germ line |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |